Table 1. Outcomes of metoidioplasty with urethral lengthening gender affirming surgery.
| First author | Publication year | N | LOF (m) | One stage, n (%) | Standing to pee, n (%) | Phallic length, Avg cm [SD] | Wound complication, n (%) | Stricture, n (%) | Fistula, n (%) | Mucocele, n (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| Al-Tamimi | 2018 | 12 | 24 | NR | NR | 7 [5–10.5] | NR | NR | 1 (8%) | NR |
| Bizic | 2019 | 793* | NR | 793 (100%) | 793 (100%) | 5.6 [4–10] | NR | 11 (1%) | 70 (9%) | **96 (12%) |
| Perovic | 2003 | 22 | 48 | 22 (100%) | NR | 5.7 [4–10] | NR | 2 (9%) | 3 (14%) | NR |
| Takamatsu | 2009 | 33 | 30 | 33 (100%) | 16 (48%) | NR | 9 (27%) | 6 (18%) | 14 (42%) | NR |
| Van de Grift | 2017 | 2 | 32 | 2 (100%) | NR | NR | 2 (100%) | 2 (33%) | 0 (0%) | NR |
| Veerman | 2020 | 8 | 23 | NR | NR | NR | NR | 5 (63%) | 4 (50%) | 1 (1%) |
| ***Avg | 146 | 28 | 81% | 74% | 6 | 63% | 25% | 21% | 6% |
*, 791 or >99% had colpectomy; **, two patients in series had no vaginectomy performed; ***, Avg of reported study outcomes. NR, not reported; LOF, length of follow up; mo, months; Avg, average; SD, standard deviation.